What is Iveda Solutions, Inc. Warrant's earnings per share (EPS)?

Iveda Solutions, Inc. Warrant (IVDAW) reported diluted earnings per share of -$0.88 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Iveda Solutions, Inc. Warrant (IVDAW) Financials

IVDAW

Trailing 12 months to June 30, 2026

Revenue $4.6M -36.0% YoY

Net Income -$3.2M +8.2% YoY

EPS (Diluted) -$0.88 FY2025 annual

Operating Cash Flow -$2.9M +18.2% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IVDAW SEC filings page.

Iveda Solutions, Inc. Warrant (IVDAW) reported $4.6M in revenue over the twelve months to Jun 30, 2026, down 36.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IVDAW FY2025 2026-08-30

External financing supports the business while 2025 cost reductions improved margins and cash use despite a shrinking revenue base.

Revenue contracted in FY2025 while gross margin expanded from 21.6% to 24.1%; the improvement points to lower cost intensity or mix, not volume-led growth. Operating cash flow improved from -$4.4M to -$2.0M, but remained negative, so narrower accounting losses still did not translate into self-funded operations.

Total liabilities fell from $2.7M in FY2024 to $1.6M in FY2025, reducing claims against the business. That strengthening coincided with $4.6M of financing cash flow while operating cash flow was -$2.0M, indicating a financing-led balance-sheet improvement rather than one generated by operations.

Gross profit was $1.3M against $4.3M of SG&A, so overhead still outweighed the gross economics of the business. That left an operating loss of -$3.2M even after R&D fell to $171K, showing the remaining cost base is the central constraint.

Financial Health Signals

Financial Health Score 55/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Iveda Solutions, Inc. Warrant's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Iveda Solutions, Inc. Warrant held $5.2M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $2.0M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Iveda Solutions, Inc. Warrant scores 56/100 among other emerging companies.

Dilution

Iveda Solutions, Inc. Warrant had 11M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Iveda Solutions, Inc. Warrant scores 80/100 among other emerging companies.

R&D Intensity

Iveda Solutions, Inc. Warrant spent $171K on research and development in fiscal year 2025, which was 2.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Iveda Solutions, Inc. Warrant scores 13/100 among other emerging companies.

Revenue Progress

Iveda Solutions, Inc. Warrant reported revenue of $5.3M in fiscal year 2025, against $6.0M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Iveda Solutions, Inc. Warrant scores 31/100 among other emerging companies.

Burn Trend

Iveda Solutions, Inc. Warrant's operations used $2.0M of cash in fiscal year 2025, against $4.4M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Iveda Solutions, Inc. Warrant scores 65/100 among other emerging companies.

Balance Sheet

Iveda Solutions, Inc. Warrant's cash, cash equivalents and investments came to $5.2M at the end of fiscal year 2025, against $1.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Iveda Solutions, Inc. Warrant scores 83/100 among other emerging companies.

Piotroski F-Score Neutral

5/9

Iveda Solutions, Inc. Warrant passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Iveda Solutions, Inc. Warrant reported a net loss of $3.2M while operations used $2.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Iveda Solutions, Inc. Warrant reported an operating loss of $3.2M against $37K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$802K

YoY-47.5%

QoQ-46.3%

5Y CAGR+7.4%

Iveda Solutions, Inc. Warrant generated $802K in revenue in Q2 2026. This represents a decrease of 47.5% from the same quarter a year earlier. Against the prior quarter it is down 46.3%.

EBITDA

-$704K

YoY-33.8%

QoQ-25.8%

Iveda Solutions, Inc. Warrant's EBITDA was -$704K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 33.8% from the same quarter a year earlier. Against the prior quarter it is down 25.8%.

Net Income

-$793K

YoY-40.6%

QoQ-48.9%

Iveda Solutions, Inc. Warrant reported -$793K in net income in Q2 2026. This represents a decrease of 40.6% from the same quarter a year earlier. Against the prior quarter it is down 48.9%.

EPS (Diluted)

-$0.07

QoQ-16.7%

Iveda Solutions, Inc. Warrant earned -$0.07 per diluted share (EPS) in Q2 2026. Against the prior quarter it is down 16.7%.

Cash & Balance Sheet

Cash & Debt

$4.8M

YoY+199.1%

QoQ-15.4%

Iveda Solutions, Inc. Warrant held $4.8M in cash against $199K in long-term debt as of Q2 2026.

Shares Outstanding

13M

QoQ+8.0%

Iveda Solutions, Inc. Warrant had 13M shares outstanding in Q2 2026. Against the prior quarter it is up 8.0%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

54.7%

YoY+25.6pp

QoQ+21.6pp

5Y change+30.9pp

Iveda Solutions, Inc. Warrant's gross margin was 54.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 25.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 21.6 percentage points.

Operating Margin

-88.6%

YoY-53.7pp

QoQ-50.7pp

Iveda Solutions, Inc. Warrant's operating margin was -88.6% in Q2 2026, reflecting core business profitability. This is down 53.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 50.7 percentage points.

Net Margin

-99.0%

YoY-62.0pp

QoQ-63.3pp

Iveda Solutions, Inc. Warrant's net profit margin was -99.0% in Q2 2026, showing the share of revenue converted to profit. This is down 62.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 63.3 percentage points.

Return on Equity

-14.7%

YoY+23.4pp

QoQ-5.6pp

Iveda Solutions, Inc. Warrant's ROE was -14.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 23.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.6 percentage points.

Capital Allocation

R&D Spending

$98K

YoY+89.8%

QoQ+225.9%

Iveda Solutions, Inc. Warrant invested $98K in research and development in Q2 2026. This represents an increase of 89.8% from the same quarter a year earlier. Against the prior quarter it is up 225.9%.

Share Buybacks

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

IVDAW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IVDAW quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$4.6M	$5.3M-12.3%	$6.0M-7.3%	$6.5M+45.4%	$4.5M+133.0%	$1.9M+29.2%	$1.5M	$3.1M+40.5%	$2.2M-34.7%	$3.3M-7.3%	$3.6M+28.0%	$2.8M+199.9%	$940K
Cost of Revenue	$3.1M	$4.0M-15.1%	$4.7M-13.1%	$5.4M+54.9%	$3.5M+222.8%	$1.1M+9.5%	$992K	$2.4M+48.2%	$1.6M-40.9%	$2.7M-15.5%	$3.2M+50.0%	$2.2M+266.5%	$588K
Gross Profit	$1.5M	$1.3M-2.2%	$1.3M+21.9%	$1.1M+10.8%	$964K+15.8%	$832K+68.9%	$493K	$682K+18.8%	$574K-6.9%	$616K+62.7%	$379K-43.0%	$665K+88.6%	$352K
R&D Expenses	$214K	$171K-53.0%	$363K-54.4%	$797K	N/A	N/A	N/A	$265K-12.9%	$304K+6.4%	$286K	N/A	N/A	N/A
SG&A Expenses	$4.4M	$4.3M-13.6%	$5.0M+16.2%	$4.3M+0.4%	$4.3M+20.7%	$3.6M+106.7%	$1.7M	$4.0M-27.4%	$5.5M-15.8%	$6.6M+55.7%	$4.2M+3.2%	$4.1M+79.2%	$2.3M
Operating Income	-$3.1M	-$3.2M+20.7%	-$4.1M-0.7%	-$4.0M-21.4%	-$3.3M-22.2%	-$2.7M-121.8%	-$1.2M	-$3.3M+32.7%	-$5.0M+27.1%	-$6.8M-76.9%	-$3.8M+12.3%	-$4.4M-126.9%	-$1.9M
EBITDA	N/A	-$3.2M+20.6%	-$4.0M-0.4%	-$4.0M-21.4%	-$3.3M-22.2%	-$2.7M-125.3%	-$1.2M	-$3.1M+33.6%	-$4.7M+28.0%	-$6.6M-81.4%	-$3.6M+12.2%	-$4.1M-123.3%	-$1.8M
Interest Expense	$31K	$37K+39.4%	$26K+260.9%	$7K-86.4%	$53K-80.5%	$274K-31.4%	$399K	$397K-17.0%	$479K+472.3%	$84K+4.8%	$80K+152.7%	$32K+86.5%	$17K
Income Tax	N/A	$30K-5.9%	$32K+76.9%	$18K+521.2%	$3K	N/A	N/A	$13K-20.6%	$16K+122.8%	-$69K+16.0%	-$83K-275.4%	$47K	N/A
Net Income	-$3.2M	-$3.2M+19.7%	-$4.0M+3.9%	-$4.1M-23.8%	-$3.3M-11.6%	-$3.0M-87.1%	-$1.6M	-$3.8M-350.9%	-$839K+87.7%	-$6.8M-77.0%	-$3.8M+13.9%	-$4.5M-129.1%	-$1.9M
EPS (Basic)	N/A	-$0.88+51.4%	-$1.81+12.6%	-$2.07-696.2%	-$0.26+23.5%	-$0.34-1033.3%	-$0.03	N/A	-$0.21+22.2%	-$0.27	N/A	N/A	N/A
EPS (Diluted)	—	-$0.88	-$1.81	-$2.07	-$0.26	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	4M	2M	2M	13M	9M-82.7%	52M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$802K-47.5%	$1.5M+1.3%	$626K-64.1%	$1.7M-31.1%	$1.5M-0.4%	$1.5M+325.2%	$1.7M+69.7%	$2.4M+174.8%
Cost of Revenue	$363K-66.5%	$999K-15.8%	$603K-60.7%	$1.1M-42.9%	$1.1M+4.9%	$1.2M+619.5%	$1.5M+76.7%	$2.0M+171.9%
Gross Profit	$439K-1.4%	$495K+71.8%	$23K-89.1%	$517K+26.0%	$445K-11.3%	$288K+58.5%	$208K+31.6%	$410K+189.7%
R&D Expenses	$98K+89.8%	$30K-9.1%	$61K+152.3%	$26K-34.4%	$52K-53.9%	$33K-82.5%	$24K	$39K
SG&A Expenses	$1.1M+13.5%	$1.0M-5.5%	$1.6M-5.8%	$706K-28.0%	$926K-7.2%	$1.1M-17.7%	$1.7M+51.7%	$980K-6.5%
Operating Income	-$710K-33.4%	-$566K+32.3%	-$1.6M-8.1%	-$214K+64.8%	-$532K+12.5%	-$836K+37.3%	-$1.5M+13.7%	-$609K+32.9%
EBITDA	-$704K-33.8%	-$560K+32.4%	-$1.6M-8.3%	-$212K+64.8%	-$526K+12.4%	-$828K+37.4%	-$1.5M+14.1%	-$601K+32.9%
Interest Expense	$6K-47.9%	$6K-3.3%	$7K-35.1%	$12K+98.0%	$12K+131.9%	$6K+35.3%	$11K+712.3%	$6K+146.0%
Income Tax	$114K+283.2%	N/A	N/A	$665+607.6%	$30K+2280.3%	N/A	-$80-6.7%	-$131+36.4%
Net Income	-$793K-40.6%	-$533K+32.9%	-$1.6M-7.1%	-$221K+61.9%	-$564K+5.8%	-$794K+38.5%	-$1.5M+24.7%	-$581K+29.9%
EPS (Basic)	-$0.07+65.0%	-$0.06+78.6%	-$0.34+44.3%	-$0.07+74.1%	-$0.20+33.3%	-$0.28+56.3%	-$0.61-771.4%	-$0.27+34.1%
EPS (Diluted)	-$0.07	-$0.06	-$0.34	-$0.07	-$0.20	-$0.28+56.3%	-$0.61	-$0.27
Diluted Shares (Avg)	12M	9M	N/A	3M	3M	3M+38.9%	N/A	2M

IVDAW Balance Sheet

IVDAW quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$6.4M+24.1%	$5.2M-17.9%	$6.3M-36.1%	$9.9M+230.1%	$3.0M+139.9%	$1.2M	$2.4M-29.7%	$3.5M-5.3%	$3.7M-25.2%	$4.9M+26.7%	$3.9M+270.9%	$1.0M
Current Assets	$6.2M+22.5%	$5.0M-14.9%	$5.9M-38.2%	$9.6M+257.3%	$2.7M+171.6%	$985K	$2.0M-19.1%	$2.5M-4.8%	$2.6M-21.4%	$3.3M+33.6%	$2.5M+239.1%	$726K
Cash & Equivalents	$5.2M+96.1%	$2.6M-44.5%	$4.7M-35.2%	$7.3M+427.8%	$1.4M+455.2%	$250K	$207K+135.4%	$88K-84.3%	$560K+389.0%	$114K-86.5%	$850K+139.3%	$355K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$236K+59.3%	$148K-54.4%	$325K-38.4%	$526K+52.8%	$345K+55.3%	$222K	$177K-54.4%	$388K+17.0%	$331K+169.4%	$123K+53.7%	$80K+1620.8%	$5K
Accounts Receivable	$257K-79.9%	$1.3M+354.6%	$281K-77.0%	$1.2M+148.1%	$493K+117.4%	$227K	$997K+177.7%	$359K-3.7%	$373K-81.0%	$2.0M+107.7%	$943K+160.7%	$362K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$841K0.0%	$841K	N/A
Total Liabilities	$1.6M-38.4%	$2.7M+83.3%	$1.5M-36.4%	$2.3M-39.1%	$3.8M-24.0%	$5.0M	$4.1M-3.8%	$4.2M+34.3%	$3.2M-15.6%	$3.7M+159.2%	$1.4M+172.9%	$529K
Current Liabilities	$1.3M-44.8%	$2.3M	N/A	$2.1M-38.6%	$3.4M-24.5%	$4.5M	$3.4M-13.7%	$4.0M+45.7%	$2.7M-25.8%	$3.7M+156.4%	$1.4M+178.1%	$515K
Non-Current Liabilities	$381K+1.2%	$376K+289.2%	-$199K-204.2%	$191K-43.7%	$339K-18.5%	$416K	$653K+139.4%	$273K-37.2%	$434K+541.8%	$68K+546.9%	$10K-23.1%	$14K
Long-Term Debt	$266K-29.3%	$376K	N/A	$191K-43.7%	$339K	N/A	N/A	$0-100.0%	$364K+438.3%	$68K	$0	N/A
Total Equity	$4.8M+90.8%	$2.5M-46.1%	$4.6M-38.6%	$7.6M+1073.9%	-$777K+79.0%	-$3.7M	-$1.6M-115.4%	-$756K-245.0%	$522K-55.8%	$1.2M-51.6%	$2.4M+370.9%	$518K
Retained Earnings	-$56.4M-6.0%	-$53.2M-8.1%	-$49.2M-10.0%	-$44.7M-8.1%	-$41.4M-7.9%	-$38.3M	-$31.9M-16.1%	-$27.5M-26.1%	-$21.8M-45.3%	-$15.0M-34.4%	-$11.2M-66.7%	-$6.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$7.0M+59.1%	$7.9M+73.5%	$6.4M+24.1%	$5.8M-36.2%	$4.4M-35.0%	$4.5M-31.4%	$5.2M-17.9%	$9.1M+13.0%
Current Assets	$6.7M+63.2%	$7.5M+78.7%	$6.2M+22.5%	$5.5M-28.2%	$4.1M-23.4%	$4.2M-20.2%	$5.0M-14.9%	$7.6M+10.0%
Cash & Equivalents	$4.8M+199.1%	$5.6M+126.2%	$5.2M+96.1%	$3.3M-8.3%	$1.6M-44.3%	$2.5M-36.1%	$2.6M-44.5%	$3.6M-35.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$243K-11.8%	$248K+13.9%	$236K+59.3%	$248K-80.9%	$275K-64.3%	$218K-55.6%	$148K-54.4%	$1.3M+165.6%
Accounts Receivable	$303K-77.8%	$745K-9.1%	$257K-79.9%	$1.3M-38.7%	$1.4M+29.0%	$820K+302.0%	$1.3M+354.6%	$2.2M+391.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$1.6M-45.8%	$2.0M-29.5%	$1.6M-38.4%	$2.0M-43.1%	$2.9M-26.1%	$2.8M-13.8%	$2.7M+83.3%	$3.5M+163.8%
Current Liabilities	$1.3M-46.6%	$1.7M-29.0%	$1.3M-44.8%	$1.6M-49.3%	$2.4M+15.6%	$2.3M+58.3%	$2.3M	$3.1M+132.4%
Non-Current Liabilities	$294K-42.0%	$334K-31.6%	$381K+1.2%	$433K+3.2%	$507K-72.8%	$489K-72.9%	$376K+289.2%	$420K+41996100.0%
Long-Term Debt	$199K-45.5%	$230K-32.7%	$266K-29.3%	$306K-27.0%	$365K-17.1%	$341K-29.0%	$376K	$420K
Total Equity	$5.4M+265.2%	$5.9M+244.8%	$4.8M+90.8%	$3.8M-8.1%	$1.5M-47.4%	$1.7M-48.8%	$2.5M-46.1%	$4.1M-38.6%
Retained Earnings	-$57.7M-5.8%	-$56.9M-5.4%	-$56.4M-6.0%	-$54.8M-9.3%	-$54.5M-10.1%	-$54.0M-10.0%	-$53.2M-8.1%	-$50.1M-7.0%

Not reported in any period shown, so not listed: Goodwill.

IVDAW Cash Flow Statement

IVDAW quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	-$2.9M	-$2.0M+54.1%	-$4.4M-32.6%	-$3.3M+38.4%	-$5.4M-174.3%	-$2.0M-1254.8%	-$146K	-$2.7M+47.1%	-$5.0M-39.3%	-$3.6M-8.5%	-$3.3M-57.8%	-$2.1M+0.2%	-$2.1M
Depreciation & Amortization	N/A	$22K-32.1%	$32K+61.0%	$20K+11.0%	$18K+18.5%	$15K-41.6%	$26K	$192K-15.1%	$226K+1.6%	$222K+1.7%	$218K-14.7%	$256K+208.7%	$83K
Stock-Based Compensation	N/A	$376K+206.7%	$123K+17.2%	$105K-13.3%	$121K-85.0%	$802K+385.5%	$165K	$217K-41.9%	$373K+10.9%	$336K+35.6%	$248K-51.9%	$515K+92.9%	$267K
Capital Expenditures	N/A	N/A	$3K-97.0%	$86K+504.3%	$14K-42.2%	$25K+11.9%	$22K	$27K-89.8%	$269K+70.9%	$157K-53.6%	$339K+120.6%	$154K+13.7%	$135K
Free Cash Flow	N/A	N/A	-$4.4M-29.3%	-$3.4M+37.0%	-$5.4M-171.6%	-$2.0M-1092.1%	-$167K	-$2.7M+49.2%	-$5.3M-40.6%	-$3.8M-2.8%	-$3.7M-62.1%	-$2.3M-0.6%	-$2.2M
Investing Cash Flow	N/A	N/A	-$3K+99.0%	-$266K-1775.0%	-$14K+42.2%	-$25K-11.9%	-$22K	-$9K+96.5%	-$269K-70.9%	-$157K+53.6%	-$339K-157.7%	$587K+534.6%	-$135K
Financing Cash Flow	$6.2M	$4.6M+101.6%	$2.3M+120.8%	$1.0M-91.0%	$11.4M+265.3%	$3.1M+2645.7%	$114K	$2.8M-42.2%	$4.8M+14.6%	$4.2M+44.6%	$2.9M+43.1%	$2.0M-21.1%	$2.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3K	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$1.4M-7.9%	-$927K-636.0%	-$252K+71.6%	-$317K+74.4%	-$1.3M-33.3%	-$126K+90.3%	-$890K+36.0%	-$1.2M+54.8%
Depreciation & Amortization	$6K-2.6%	$6K-19.4%	$6K-31.0%	$3K-66.0%	$6K-23.4%	$7K-7.8%	$8K+455.5%	$8K-28.1%
Stock-Based Compensation	$12K	$12K	N/A	N/A	$0-100.0%	$0	N/A	$0
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	-$7-99.9%	-$300K-13.8%
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	-$890K+36.3%	-$1.5M+50.1%
Investing Cash Flow	N/A	N/A	N/A	N/A	-$1K-100.7%	$109+100.1%	$7-100.0%	$11+100.0%
Financing Cash Flow	$558K+75.4%	$1.4M+169916.6%	$2.2M+3807.8%	$2.1M+14.6%	$318K+4321.4%	$839-99.8%	-$59K-157.4%	$1.8M+2390.5%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

IVDAW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IVDAW quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	24.1%+2.5pp	21.6%+5.2pp	16.4%-5.1pp	21.6%-21.8pp	43.4%+10.2pp	33.2%	22.2%-4.1pp	26.2%+7.8pp	18.4%+7.9pp	10.5%-13.1pp	23.6%-13.9pp	37.5%
Operating Margin	-61.1%+6.5pp	-67.6%-5.4pp	-62.2%+12.3pp	-74.5%	-142.1%	-82.8%	-108.6%	-226.9%	-203.3%	-106.5%	-155.6%	-205.6%
Net Margin	-60.6%+5.5pp	-66.1%-2.3pp	-63.8%+11.1pp	-74.9%	-156.3%	-107.9%	-123.2%	-38.4%	-203.3%	-106.5%	-158.3%	-207.3%
Return on Equity	-66.9%+92.0pp	-158.9%-69.8pp	-89.1%-44.9pp	-44.2%	N/A	N/A	N/A	N/A	-1303.5%-978.1pp	-325.4%-142.4pp	-183.0%+193.2pp	-376.1%
Return on Assets	-49.8%+27.1pp	-76.9%-11.2pp	-65.7%-31.8pp	-33.9%+66.5pp	-100.4%+28.3pp	-128.6%	-154.6%-130.5pp	-24.1%+160.8pp	-184.9%-106.8pp	-78.1%+36.9pp	-115.0%+71.2pp	-186.2%
Current Ratio	4.86+2.7x	2.19	N/A	4.55+3.8x	0.78+0.6x	0.22	0.580.0x	0.62-0.3x	0.95+0.1x	0.90-0.8x	1.72+0.3x	1.41
Debt-to-Equity	0.06-0.1x	0.15-0.2x	0.31+0.3x	0.03	N/A	N/A	N/A	N/A	0.70+0.6x	0.06+0.1x	0.00-1.0x	1.02
Asset Turnover	0.82-0.3x	1.16+0.1x	1.03+0.6x	0.45-0.2x	0.64-0.5x	1.19	1.25+0.6x	0.63-0.3x	0.91+0.2x	0.730.0x	0.73-0.2x	0.90
FCF Margin	N/A	-73.5%-20.8pp	-52.6%	-121.4%	-104.1%	-11.3%	-87.6%	-242.5%	-112.7%	-101.6%	-80.3%	-239.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	54.7%+25.6pp	33.1%+13.6pp	3.6%-8.3pp	31.3%+14.2pp	29.1%-3.6pp	19.6%-32.9pp	11.9%-3.5pp	17.1%+0.9pp
Operating Margin	-88.6%-53.7pp	-37.9%+18.8pp	-262.7%	-13.0%+12.4pp	-34.8%+4.8pp	-56.7%	-87.3%	-25.4%
Net Margin	-99.0%-62.0pp	-35.7%+18.2pp	-258.6%	-13.4%+10.8pp	-36.9%+2.1pp	-53.8%	-86.8%	-24.2%+70.7pp
Return on Equity	-14.7%+23.4pp	-9.1%+37.6pp	-33.9%+26.4pp	-5.9%+8.3pp	-38.1%-16.8pp	-46.7%-7.8pp	-60.3%-17.1pp	-14.2%-1.8pp
Return on Assets	-11.4%+1.5pp	-6.8%+10.8pp	-25.2%+4.0pp	-3.8%+2.6pp	-12.8%-4.0pp	-17.5%+2.0pp	-29.2%+2.6pp	-6.4%+3.9pp
Current Ratio	5.19+3.5x	4.53+2.7x	4.86+2.7x	3.48+1.0x	1.70-0.9x	1.80-1.8x	2.19	2.45-2.7x
Debt-to-Equity	0.04-0.2x	0.04-0.2x	0.06-0.1x	0.080.0x	0.25+0.1x	0.20+0.1x	0.15-0.2x	0.10-0.1x
Asset Turnover	0.11-0.2x	0.19-0.1x	0.10-0.2x	0.290.0x	0.35+0.1x	0.33+0.3x	0.34+0.2x	0.26+0.2x
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	-51.1%	-64.1%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Iveda Solutions, Inc. Warrant IVDAW	FY2025	$5.3M	-$3.2M	-60.6%	N/A	55/100
Guardforce AI Co., Limited Warrant GFAIW	FY2020	N/A	$3.1M	N/A	N/A	—
Bridger Aerospace Group Holdings, Inc. Warrant BAERW	FY2025	$122.8M	$4.1M	3.4%	N/A	54/100
Iveda Solutions, Inc. IVDA	FY2025	$5.3M	-$3.2M	-60.6%	$3.6M	55/100
Guardforce AI Co., Limited GFAI	FY2025	$35.2M	-$6.6M	-18.9%	$11.3M	32/100
SuperCom, Ltd SPCB	FY2025	$27.9M	$3.7M	13.4%	$62.6M	47/100

Where Iveda Solutions, Inc. Warrant Ranks

Frequently Asked Questions

What is Iveda Solutions, Inc. Warrant's annual revenue?

Iveda Solutions, Inc. Warrant (IVDAW) reported $5.3M in total revenue for fiscal year 2025. This represents a -12.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Iveda Solutions, Inc. Warrant's revenue growing?

Iveda Solutions, Inc. Warrant (IVDAW) revenue declined by 12.3% year-over-year, from $6.0M to $5.3M in fiscal year 2025.

Is Iveda Solutions, Inc. Warrant profitable?

No, Iveda Solutions, Inc. Warrant (IVDAW) reported a net income of -$3.2M in fiscal year 2025, with a net profit margin of -60.6%.

What is Iveda Solutions, Inc. Warrant's EBITDA?

Iveda Solutions, Inc. Warrant (IVDAW) had EBITDA of -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Iveda Solutions, Inc. Warrant have?

As of fiscal year 2025, Iveda Solutions, Inc. Warrant (IVDAW) had $5.2M in cash and equivalents against $266K in long-term debt.

What is Iveda Solutions, Inc. Warrant's gross margin?

Iveda Solutions, Inc. Warrant (IVDAW) had a gross margin of 24.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Iveda Solutions, Inc. Warrant's operating margin?

Iveda Solutions, Inc. Warrant (IVDAW) had an operating margin of -61.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Iveda Solutions, Inc. Warrant's net profit margin?

Iveda Solutions, Inc. Warrant (IVDAW) had a net profit margin of -60.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Iveda Solutions, Inc. Warrant's return on equity (ROE)?

Iveda Solutions, Inc. Warrant (IVDAW) has a return on equity of -66.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Iveda Solutions, Inc. Warrant's operating cash flow?

Iveda Solutions, Inc. Warrant (IVDAW) recorded an outflow of $2.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Iveda Solutions, Inc. Warrant's total assets?

Iveda Solutions, Inc. Warrant (IVDAW) had $6.4M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Iveda Solutions, Inc. Warrant spend on research and development?

Iveda Solutions, Inc. Warrant (IVDAW) invested $171K in research and development during fiscal year 2025.

How many shares does Iveda Solutions, Inc. Warrant have outstanding?

Iveda Solutions, Inc. Warrant (IVDAW) had 11M shares outstanding as of fiscal year 2025.

What is Iveda Solutions, Inc. Warrant's current ratio?

Iveda Solutions, Inc. Warrant (IVDAW) had a current ratio of 4.86 as of fiscal year 2025, which is generally considered healthy.

What is Iveda Solutions, Inc. Warrant's debt-to-equity ratio?

Iveda Solutions, Inc. Warrant (IVDAW) had a debt-to-equity ratio of 0.06 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Iveda Solutions, Inc. Warrant's return on assets (ROA)?

Iveda Solutions, Inc. Warrant (IVDAW) had a return on assets of -49.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Iveda Solutions, Inc. Warrant's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Iveda Solutions, Inc. Warrant (IVDAW) held $5.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.0M over that year. Dividing the one by the other, the reported balance equals about 31 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Iveda Solutions, Inc. Warrant's Piotroski F-Score?

Iveda Solutions, Inc. Warrant (IVDAW) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Iveda Solutions, Inc. Warrant's earnings high quality?

Iveda Solutions, Inc. Warrant (IVDAW) reported a net loss of $3.2M while operations used $2.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Iveda Solutions, Inc. Warrant cover its interest payments?

Iveda Solutions, Inc. Warrant (IVDAW) reported an operating loss of $3.2M against $37K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Iveda Solutions, Inc. Warrant?

Iveda Solutions, Inc. Warrant (IVDAW) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.